Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Back
Share this video  

ISAL 2019 | Prevention, detection and treatment of AML relapse after allo-SCT

Thomas Schröder • 14 Mar 2019
ISAL 2019
Acute Myeloid Leukemia Leukemia

Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses the prevention, detection and treatment of the acute myeloid leukemia (AML) relapse after allogeneic stem cell transplantation. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

More from Thomas Schröder

2:47
Management of relapse following alloHSCT in patients with AML and MDS
Thomas Schröder • 5 Oct 2021
1:54
New developments in AML treatment
Thomas Schröder • 5 Oct 2021
1:27
Progress in AML & research at the University of Düsseldorf
Thomas Schröder • 15 Mar 2019

Related Videos

2:00
BTK degraders in CLL and lymphoma: a Phase I trial of NX-5948
Dima El-Sharkawi • 28 Apr 2024
2:04
Increasing awareness of germline predispositions to hematological malignancies in pediatric patients
Anupama Rao • 29 Apr 2024
0:57
The development of a UK AML registry
Priyanka Mehta • 22 Apr 2024
5:27
Young matched unrelated donors versus older-aged matched sibling donors in alloSCT with PTCy
Karthik Nath • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals